Bayer’s stock is jumping on secondary stroke drug’s trial success
Bayer stock jumped on Monday after the German healthcare company said a late-stage stroke drug trial achieved its goals.
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
